Asbestos & Mesothelioma Studies

Keytruda and Chemotherapy Improve Survival in Mesothelioma Patients

The U.S Food and Drug Administration has accepted a priority review for a new Supplemental Biologics License Application. This could be a new era in the management of pleural mesothelioma, leading to a better future for those diagnosed with the cancer. The review is looking for approval of Keytruda used[…]

Read More »

Palliative Care Improves Lives of Mesothelioma Patients

Palliative care is an essential part of the cancer treatment process. It helps improve the quality of life of people with life threatening illnesses like mesothelioma. It is important for doctors to know the range of symptoms patients experience to help provide the best care possible. Palliative care is a[…]

Read More »

Delayed Care for Mesothelioma Could be Beneficial for Patients

Mesothelioma, a cancer mainly caused by asbestos, is very hard to treat. A new study wanted to see if treating mesothelioma immediately is the best option for certain patients. The study, which was published in Clinical Lung Cancer, looks at patients with inoperable pleural mesothelioma. The study compared patients who[…]

Read More »

Surgery Improves Survival in Mesothelioma Patients

There is a debate about whether surgery for mesothelioma is beneficial. A new study was presented at the World Conference on Lung Cancer. The study looked at the survival of pleural mesothelioma patients who had different types of treatment. These included chemotherapy followed by surgery and chemotherapy only. The goal[…]

Read More »

How the Immune System is Affected by Pleural Mesothelioma

A recent study looked at the body’s immune system and how it responds to pleural mesothelioma, a cancer of the lining of the lungs. Results were published in the journal Pathobiology. The immune cells around the tumor area of 60 pleural mesothelioma patients were studied. The researchers used biomarkers to[…]

Read More »

Exposure to Asbestos With BAP1 Mutation Increases Risk of Mesothelioma

In a study presented today at the American Association for Cancer Research Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that mice with a BAP1 germline mutation, after exposure to small levels of asbestos, had a greater chance of developing malignant mesothelioma. The study is being published in[…]

Read More »

Researchers Looked at Fibroblasts to Determine Their Role in Mesothelioma Growth

Malignant mesothelioma is a hard cancer to treat and is mainly caused by asbestos. It was widely used in construction, steel mills, and other industries. Mesothelioma is especially hard to treat because it grows and spreads quickly. There are unfortunately not many options for the treatment of mesothelioma. It takes[…]

Read More »

Targeting uPARAP Could Improve Mesothelioma Treatment

Mesothelioma is a hard cancer to treat that has low survival rates. This makes it a problem for doctors and researchers. A new study is looking to change this by looking at the collagen receptor uPARAP. The current clinical trial is looking at uPARAP, a protein that is found in[…]

Read More »